Plant regulator seed treatment for enhanced legume nodulation
A novel plant regulator seed treatment designed to enhance legume nodulation by manipulating plant stress pathways. This method promotes Rhizobium survival and nodulation in chickpeas, offering a cost-effective alternative to traditional breeding or genetic modification.
Overview
This innovative solution involves a novel chemical seed treatment that enhances the nodulation of legumes by manipulating plant stress pathways. By applying a specific plant regulator that activates cytoprotective pathways, this method significantly improves the survival and nodulation of Rhizobium bacteria in chickpeas. This approach offers a cost-effective, safe, and efficient alternative to traditional breeding or genetic modification, potentially enhancing nitrogen fixation in legumes more effectively.
Technical specifications
Key features:
- Utilizes a novel plant regulator to enhance chickpea nodulation
- Activates cytoprotective pathways to prevent initial cell death during Rhizobium infection
- Proven effectiveness in glasshouse trials without impacting plant growth
- Provides a targeted chemical seed treatment as an alternative to genetic modification
Applications:
- Improves nitrogen fixation in chickpeas, which are globally significant legumes
- Potentially applicable to other legume species under similar conditions
Technology readiness level
This technology is currently at TRL 4, having demonstrated promising results in controlled glasshouse environments. The next phase involves field trials to validate performance across different genotypes and environmental conditions. The project seeks partnerships to support these trials and further development.
About Queensland University of Technology
Queensland University of Technology (QUT) is a major Australian public research university in Brisbane with two inner-city campuses and a practical, industry-focused culture. Industry partners tap shared core laboratories and technical staff through the Central Analytical Research Facility, and collaborate with QUT groups at the Translational Research Institute alongside hospital partners. A dedicated Office of Industry Engagement brokers collaborative and contract research, while entrepreneurship programs and commercialization pathways help convert university IP into ventures and licenses. Research is sustained by competitive national funding, including the Australian Research Council and National Health and Medical Research Council, with added support from programs such as the Medical Research Future Fund.
delivered to your inbox.